# Efficacy and Safety of DKB-119 in Patients in Crow's Feet

> **NCT06021418** · NA · UNKNOWN · sponsor: **Dongkook Pharmaceutical Co., Ltd.** · enrollment: 100 (actual)

## Conditions studied

- Crow's Feet

## Interventions

- **DEVICE:** DKB-119

## Key facts

- **NCT ID:** NCT06021418
- **Lead sponsor:** Dongkook Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-02
- **Primary completion:** 2023-09-08
- **Final completion:** 2023-10-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06021418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06021418, "Efficacy and Safety of DKB-119 in Patients in Crow's Feet". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT06021418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*